The online version of this article (https://doi.org/10.1186/s12884-018-1972-1) contains supplementary material, which is available to authorized users.
Preeclampsia and eclampsia (PE/E) are major contributors to maternal and neonatal deaths in developing countries, associated with 10–15% of direct maternal deaths and nearly a quarter of stillbirths and newborn deaths, many of which are preventable with improved care. We present results related to WHO-recommended interventions for screening and management of PE/E during antenatal care (ANC) and labor and delivery (L & D) from a study conducted in six sub-Saharan African countries.
From 2010 to 2012, cross-sectional studies which directly observed provision of ANC and L & D services in six sub-Saharan African countries were conducted. Results from 643 health facilities of different levels in Ethiopia (n = 19), Kenya (n = 509), Madagascar (n = 36), Mozambique (n = 46), Rwanda (n = 72), and Tanzania (n = 52), were combined for this analysis. While studies were sampled separately in each country, all used standardized observation checklists and inventory assessment tools.
2920 women receiving ANC and 2689 women in L & D were observed. Thirty-nine percent of ANC clients were asked about PE/E danger signs, and 68% had their blood pressure (BP) taken correctly (range 48–96%). Roughly half (46%) underwent testing for proteinuria. Twenty-three percent of women in L & D were asked about PE/E danger signs (range 11–34%); 77% had their BP checked upon admission (range 59–85%); and 6% had testing for proteinuria. Twenty-five cases of severe PE/E were observed: magnesium sulfate (MgSO4) was used in 15, not used in 5, and for 5 use was unknown. The availability of MgSO4 in L & D varied from 16% in Ethiopia to 100% in Mozambique.
Observed ANC consultations and L & D cases showed low use of WHO-recommended practices for PE/E screening and management. Availability of MgSO4 was low in multiple countries, though it was on the essential drug list of all surveyed countries. Country programs are encouraged to address gaps in screening and management of PE/E in ANC and L & D to contribute to lower maternal and perinatal mortality.
Additional file 1: Maternal and Newborn Quality of Care Survey ANC Observation Checklist. The standardized data collection tool which was modified for use in each country for data collection for ANC services. (PDF 163 kb)12884_2018_1972_MOESM1_ESM.pdf
Additional file 2: Maternal and Newborn Quality of Care Survey L & D Observation Checklist. The standardized data collection tool which was modified for use in each country for data collection for labor and delivery services. (PDF 285 kb)12884_2018_1972_MOESM2_ESM.pdf
Duley L. The Global Impact of Pre-eclampsia and Eclampsia. Semin Perinatol. Jun. 2009;33(3):130–7. CrossRef
Bilano VL, Ota E, Ganchimeg T, Mori R, Souza JP. Risk factors of pre-eclampsia/eclampsia and its adverse outcomes in low- and middle-income countries: A WHO secondary analysis. PLoS One. 2014;9(3):1–9. CrossRef
Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: A systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1–7. CrossRef
Al-Safi Z, Imudia AN, Filetti LC, Hobson DT, Bahado-Singh RO, Awonuga AO. Delayed Postpartum Preeclampsia and Eclampsia Demographics, Clinical Course, and Complications. Obstet Gynecol. 2011;118(5):1102–7. CrossRef
WHO. WHO recommendations for Prevention and treatment of pre-eclampsia and eclampsia: Geneva Switzerland; 2011.
van den Broek N, Graham W. Quality of care for maternal and newborn health: the neglected agenda. BJOG An Int. J. Obstet. Gynaecol. Oct. 2009;116(s1):18–21. CrossRef
WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division. Trends in maternal mortality: 1990 to 2015. Geneva: World Health Organization; 2015.
WHO. Consultation on improving measurement of the quality of maternal, newborn and child care in health facilities. Geneva, Switzerland; 2014.
Graham WJ, Bell JS, Bullough CHW. Can skilled attendance at delivery reduce maternal mortality in developing countries? In: Safe Motherhood Strategies: A Review of the Evidence. In: De Brouwere V, Van Lerberghe W, editors. Studies in Health Services Organisation and Policy. 2001.
WHO, “WHO Core 100 Indicators Draft Report,” 2017.
The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial. Lancet. 2002;359(9321):1877–90. CrossRef
Columbia University, “Averting Death and Disability Program needs assessments, available at.” [Online]. Available: https://www.mailman.columbia.edu/research/averting-maternal-death-and-disability-amdd/toolkit. Accessed 30-Jan-2017.
WHO, “Service Availability and Readiness Assessment (SARA): Reference Manual: an annual monitoring system for service delivery,” 2013.
Measure Evaluation, “Measure DHS Service Provision Assessments,” 2016. [Online]. Available: https://dhsprogram.com/What-We-Do/Survey-Types/SPA.cfm.
WHO, UNICEF, and UNFPA, “Managing Complications in Pregnancy and Childbirth: a guide for midwives and doctors,” 2000.
de Graft-Johnson J, Vesel L, Rosen HE, Rawlins B, Abwao S, Mazia G, Bozsa R, Mwebesa W, Khadka N, Kamunya R, Getachew A, Tibaijuka G, Rakotovao JP, Tekleberhan A. Cross-sectional observational assessment of quality of newborn care immediately after birth in health facilities across six sub-Saharan African countries. BMJ Open. 2017;7(3):e014680. CrossRefPubMedPubMedCentral
Makene CL, Plotkin M, Currie S, Bishanga D, Ugwi P, Louis H, Winani K, Nelson BD. Improvements in newborn care and newborn resuscitation following a quality improvement program at scale: results from a before and after study in Tanzania. BMC Pregnancy Childbirth. 2014;14:381. CrossRefPubMedPubMedCentral
Bazant E, Rakotovao JP, Rasolofomanana JR, Tripathi V, Gomez P, Favero R, Moffson S. Qualité des soins pour prévenir et traiter l’hémorragie du postpartum et la pré-éclampsie/éclampsie: une évaluation fondée sur l’observation dans les hôpitaux de Madagascar. Med. Sante Trop. 2013;(0):1–8. http://www.jle.com/fr/revues/mst/e-docs/qualite_des_soins_pour_prevenir_et_traiter_lhemorragie_du_postpartum_et_la_pre_eclampsie_eclampsie_une_evaluation_fondee_sur_lobservation_dans_les_hopitaux_de_madagascar_298035/article.phtml?tab=texte.
MCHIP, “MCHIP QoC Study L & D Observation Form,” 2013. Available: http://www.mchip.net/sites/default/files/mchipfiles/QoC LD Observation_0.pdf. Accessed 01-Jan-2017 [Online].
MCHIP, “MCHIP QoC Study Inventory Form,” 2013. [Online]. Available: http://www.mchip.net/sites/default/files/mchipfiles/QoC Essential Inventory.pdf. Accessed 1 Jan 2017.
Measure Evaluation, “Measure DHS Service Provision Assessment Tools,” 2016. Available: https://dhsprogram.com/What-We-Do/Survey-Types/SPA.cfm.
Columbia University, “Averting Death and Disability Program needs assessments tools,” 2017. Available: https://www.mailman.columbia.edu/research/averting-maternal-death-and-disability-amdd/toolkit. Accessed 2 Feb 2017.
A. L. Ridge, L. A. Bero, and S. R. Hill, “Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia,” 2010.
Austin A, Langer A, Salam RA, Lassi ZS, Das JK, Bhutta ZA. Approaches to improve the quality of maternal and newborn health care: an overview of the evidence. Reprod. Heal. J. 2014;11(Supplement 2):S1.
- Screening and management of pre-eclampsia and eclampsia in antenatal and labor and delivery services: findings from cross-sectional observation studies in six sub-Saharan African countries
Jean Pierre Rakotovao
- BioMed Central
Neu im Fachgebiet Gynäkologie und Geburtshilfe
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II